Daniella Kushnir-Grinbaum, Michael Ziv, Rodney D Sinclair
{"title":"Short-Term Biologic Therapy for Guttate Psoriasis: Successful Treatment with Bimekizumab and Literature Review.","authors":"Daniella Kushnir-Grinbaum, Michael Ziv, Rodney D Sinclair","doi":"10.1093/ced/llaf137","DOIUrl":null,"url":null,"abstract":"<p><p>Guttate psoriasis is a psoriasis subtype often triggered by infections that may progress to chronic plaque psoriasis. While some cases resolve on their own, severe cases can be challenging to manage. Our case, along with recent reports, suggests that interim treatment with biologics such as IL-17 and IL-23 inhibitors may induce long-term remission. Further research is needed to explore the potential role of biologics as a therapeutic option for this condition.</p>","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ced/llaf137","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Guttate psoriasis is a psoriasis subtype often triggered by infections that may progress to chronic plaque psoriasis. While some cases resolve on their own, severe cases can be challenging to manage. Our case, along with recent reports, suggests that interim treatment with biologics such as IL-17 and IL-23 inhibitors may induce long-term remission. Further research is needed to explore the potential role of biologics as a therapeutic option for this condition.
期刊介绍:
Clinical and Experimental Dermatology (CED) is a unique provider of relevant and educational material for practising clinicians and dermatological researchers. We support continuing professional development (CPD) of dermatology specialists to advance the understanding, management and treatment of skin disease in order to improve patient outcomes.